|
SoCalBio Vendor Spotlight
LCS Constructors (Irvine)
A SoCalBio Member Since 2008 
Represented in SoCalBio by its VP Mr. David Skinner, LCS provides a broad range of services for laboratory design construction including new construction, laboratory design, laboratory construction, laboratory relocation, remodels and renovations, interior build-outs and tenant improvements, portable and temporary lab buildings, environmental rooms and cleanrooms .... Learn more
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
|
May 14, 2013
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
enany@socalbio.org
www.socalbio.org
|
| RSVP Now |
SoCalBio Networking Forum
May 30, 4 to 7 pm
Conference Room of the USC Stem Cell Research Institute at the USC Health Sciences Campus in East Los Angeles
Groundbreaking Technologies to
Reverse Blindness
Keynote Presenter
Robert Greenberg, MD, PhD
Co-Founder, President & CEO
Second Sight Product Corporation
Join us to get a glimpse of how SoCalBio members are changing the face of medicine. Learn about Second Sight's FDA-approved and first-in-breed bionic eye -- the Argus II -- that restores some vision to people suffering from Retinitis Pigmentosa.
The Argus II is:
- An example of new technologies under development in Southern California that promise to reverse blindness.
- A demonstration of the virtuous outcome of effective local university/industry collaborations
- The latest in a long string of many biomedical breakthrough innovations made in the Greater Los Angeles region since the 1930s that changed the face of medicine and improved patient care.
- Another landmark contribution to medicine by Los Angeles biomedical entrepreneur, philanthropist and SoCalBio Chairman Emeritus Alfred E. Mann.
|
|
Crowdfunding
|
Crowdfunding for Life Sciences Companies
|
|
Emerging Markets
|
Amgen Forms Joint Venture in China
 Amgen Inc. will form a joint venture with Chinese pharmaceutical firm Zhejiang Beta Pharma Co. to bring its colon cancer drug Vectibix to the important Chinese market. "This joint venture brings us one step closer to providing Chinese patients with Amgen's medicines and supports our strategy of expanding in key, fast-growing markets," said Anthony Hooper, executive vice president at Amgen ... Read more
|
|
China Medtech Opportunities
|
New Report Finds many Medtech Companies Buying into China
 Growth in the global medical device market might be stymied by health care reform in the U.S. and economic challenges in Europe, but a new report from Kalorama Information finds that another trend has been emerging: the acquisition of small Chinese companies by large U.S. medical device manufacturers .. Read more
|
|
Sponsored Event
|
think ASIA, think HONG KONG
June 14, 2013, Starting at 8:15 am
J W Marriott in Downtown Los Angeles
REGISTER NOW (Free Event)
 Organized by SoCalBio partner the Hong Kong Trade Development Council (HKTDC), this event is designed to promote Hong Kong as Asia's central business district, the first stop for overseas companies entering the Asian market, and the global gateway to China ... Learn more
|
| Cochlear Implants | |
Fan-Gang Zeng of UCI Center for Hearing Research Launched Nurotron to Produce Cheaper Cochlear Implants to Serve the Chinese Market
There are 28 million deaf people and 30,000 babies born without hearing each year in China. The government, the Chinese Academy of Sciences, and state-backed hospitals contributed about 75 percent of the startup's initial funding of 30 million yuan (about $3.7 million at the time). Mainland authorities were also willing to fast-track the approval process, which usually takes three to five years. After wrapping up clinical trials in 2010, Nurotron secured permission in less than a year to have its cochlear implants used in patients aged six and older ... Read more
|
| Join SoCalBio | |
Become a SoCalBio Member and Save Money by Utlizing the SoCalBio Group Purchasing Program
|
|
Drug Approval
|
Does the FDA's Breakthrough Designation for Drugs Help in Shortening Pathway to Market?
 The FDA has come up with a new breakthrough designation for drugs it views as a substantial improvement over existing therapies. With the designation - five have been awarded so far with 12 more drugs currently under consideration - the agency works more closely with drugmakers to identify approval requirements and work out commercial manufacturing issues ... Read more
|
|
Device Approval
|
FDA Aims to Change Biological Reviews of Medical Devices
 The FDA has issued draft guidance intended to help companies prepare regulatory submissions for devices that come into contact with the human body directly or indirectly. The guidance, which is up for comment until July 22, outlines changes to how the international standard ISO-10993 should be used to identify possible toxicity issues tied to those devices ... Learn more
|
|
Biosimilars
|
Amgen & Genentech Wants the California Legislature to Tightly Regulate Biosimilars
 But now other drug manufacturers want to make and sell "biosimilars." These are drugs that would be similar to biological medicines produced by companies such as Amgen and Genentech but not identical like generic drugs. These biosimilar drugs would have to be certified by the U.S. Food and Drug Administration as "interchangeable" substitutes. The FDA has not yet spelled out how this would work ... Read more
|
|
Talent Development
|
SoCalBio Contributes to Biotech/Biopharma Talent Development in Southern California:
Industry to Develop Valley College Biomanufacturing Technician Training Program
 The San Fernando Business Journal covers the SoCalBio-initiated and DOL-funded three-year project that establishes the Community College Consortium for Biosciences Credentials. This project will be centered at Los Angeloes Valley College in the San Fernando Valley. The project's objective is to develop core bio-manufacturing competencies and introduce stackable and latticed credentials to help trade-impacted workers get new jobs..... Click here to access the article
|
| Jobs Available | |
STAAR Surgical (Monrovia)
SynTouch LLP (Los Angeles)
Keck Graduate Institute (Claremont)
ImaginAB (Inglewood)
Absorption Systems (San Diego)
Replenish Inc. (Pasadena)
Click here for more info and to apply
- Electrical Engineer (REQ #:12-04)
- Facilities Maintenance Worker (REQ #:12-29)
- Process Engineer/MEMS Fabrication (REQ #:12-31)
- Process Development Engineer (REQ #:12-32)
- Process Development Engineer (REQ #:12-33)
Puma Biotechnology (Los Angeles)
Bioject (Orange County)
Helix Medical (Baldwin Park)
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
.jpg)
George